ITOC9 Committee

Conference President

• Michael von Bergwelt
  (LMU, CCC, DKTK, Munich, Germany)

 

Chairman of the Scientific Committee

• Sebastian Kobold
  (Ludwig-Maximilians-Universität, Munich, Germany)

• Volkmar Nuessler
  (TZM, Munich, Germany)
   

Scientific Committee

• Niroshana Anandasabapathy
  (Weill Cornell New York, NY, United States)

• Paolo Ascierto
  (Istituto Nazionale Tumori, Naples, Italy)

• Michael Bergmann 
  (Medical University Vienna, Austria)

• Tanja D. de Gruijl  
  (Cancer Center Amsterdam, The Netherlands)

• Rafal Dziadziuszko
  (Medical University of Gdańsk, Poland)

• Ulrich Jäger
  (Medical University of Vienna, Austria)

• Samir N. Khleif
  (Georgetown University Medical Center, United States)

• ​

• Maciej Krzakowski
  (Oncology Centre, Maria Skłodowska-Curie Institute, Warsaw, Poland) 

• Chong-Xian Pan
  (Harvard Medical School, Boston, MA, United States)

• Sine Reker Hadrup
  (Technical University of Denmark, Experimental &Translational Immunology, Lyngby, Denmark)

• Pedro Romero

• (Translational Tumor Immunology Group, University of Lausanne, Switzerland)

• José Saro
  (Vice-President, Global clinical Development, Adaptimmune Therapeutics, Abingdon, Oxfordshire, United Kingdom)

• Barbara Seliger
  (Martin Luther University Halle-Wittenberg, Germany)

• Maria Sibilia
  (Medical University of Vienna, Austria)

• Wenru Song
  (Kira Pharmaceuticals, Arlington, United States)

• Marion Subklewe
  (Ludwig-Maximilians-Universität, Munich, Germany)

• Mario Sznol
  (Yale School of Medicine, New Haven, CT, United States)

• Eric Tartour
  (Hopital Européen Georges-Pompidou, Paris, France)

• Giorgio Trinchieri
  (Center for Cancer Research, NCI, NIH, Bethesda, MD, United States)

• Lei Zheng
  (Johns Hopkins University, Baltimore, MD, United States)

• Christoph Zielinski
  (Medical University of Vienna, Austria)